Unclaimed Scholar Profile
Are you Peter B. Gilbert? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South AfricaASIDASID-6569-8120-0757 orcid.org/0000-0002-2662-9427
Peter B. Gilbert
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa•South Africa
Faculty researcher at Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, specializing in Health Sciences. [Discipline: Health Sciences]
#HIV Research and Treatment#SARS-CoV-2 and COVID-19 Research#HIV/AIDS Research and Interventions#Statistical Methods in Clinical Trials
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 31,095 | 6,112 |
| h-index | 78 | 55 |
| i10-index | 310 | 186 |
Annual Citation Growth
Verified Citations / Year0
2020611
2021+40%856
2022+29%1.1k
2023+33%1.5k
2024-8%1.3k
2025-46%733
2026Scholarship Distribution & Proportions500 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (25,498) • 18% Global Research Impact (5,597)
500 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
1Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (500)
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Published in UNC Libraries•2022
DOI: 10.1126/science.abm3425 Verified Peer-Reviewed
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Published in Journal of Virology•2005
DOI: 10.1128/jvi.79.16.10108-10125.2005 Verified Peer-Reviewed
Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand
Published in The Journal of Infectious Diseases•2006
DOI: 10.1086/508748 Verified Peer-Reviewed
Evidence for antibody as a protective correlate for COVID-19 vaccines
Published in Vaccine•2021
DOI: 10.1016/j.vaccine.2021.05.063 Verified Peer-Reviewed
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
Published in New England Journal of Medicine•2018
DOI: 10.1056/nejmoa1800820 Verified Peer-Reviewed
Showing 1 – 5 of 500 publications
1 / 100